MoneyWorks4Me

Alembic Pharmaceuticals informs about disclosure

10 Dec 2021 Evaluate

Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, Alembic Pharmaceuticals has informed that the Company has acquired Series Seed Preferred Stock of RIGlmmune, Inc. In this regard, the company enclosed a press release. The detailed disclosure pursuant to Regulation 30(2) of the aforesaid Regulations is also enclosed as Annexure-1.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..